Your browser doesn't support javascript.
loading
Longitudinal Monitoring of EGFR and PIK3CA Mutations by Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports.
Li, Ning; Guha, Udayan; Kim, Chul; Ye, Leah; Cheng, Jordan; Li, Feng; Chia, David; Wei, Fang; Wong, David T W.
Afiliación
  • Li N; Department of Oral and Maxillofacial Surgery, Xiangya Hospital, Central South University, Changsha, China.
  • Guha U; Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
  • Kim C; Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
  • Ye L; School of Dentistry, University of California, Los Angeles, Los Angeles, CA, United States.
  • Cheng J; School of Dentistry, University of California, Los Angeles, Los Angeles, CA, United States.
  • Li F; School of Dentistry, University of California, Los Angeles, Los Angeles, CA, United States.
  • Chia D; School of Dentistry, University of California, Los Angeles, Los Angeles, CA, United States.
  • Wei F; School of Dentistry, University of California, Los Angeles, Los Angeles, CA, United States.
  • Wong DTW; School of Dentistry, University of California, Los Angeles, Los Angeles, CA, United States.
Front Oncol ; 10: 1240, 2020.
Article en En | MEDLINE | ID: mdl-32793495

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza